Global footprint Midas Pharma operates across 10 locations worldwide with extensive local know-how and networks in major pharmaceutical markets, presenting cross-border collaboration and regional supplier opportunities for Finished Products, Starting Materials, and packaging.

Full value chain capability spans Starting Materials, Active Pharmaceutical Ingredients, Finished Products and Devices, enabling end-to-end partnerships for customers seeking streamlined supply chains and contract manufacturing or development services.

Strategic partnerships Recent and past collaborations with Onko Kocsel, Mithra Pharmaceuticals, and IP/technology divestitures indicate openness to co-development and manufacturing agreements, suggesting targeting for sterile injectables, pre-filled syringes, and autoinjectors.

Tech enablement Adoption of SAP, Microsoft Power Platform, SharePoint and Salesforce indicates a modern enterprise stack; leverages data and CRM capabilities to pursue opportunities in enterprise customers, procurement programs, and digital collaboration with clients.

Financial scale Revenue in the tens-to-hundreds of millions range and a mid-sized employee base signal capacity to take on mid-scale CDMO programs, while potential for growth through targeted marketing to mid-tier global pharma buyers seeking reliable manufacturing partnerships.